To identify the molecular determinants for attenuation of wild-type Japanese encephalitis (JE) virus strain SA14, the RNA genome of wild-type strain SA14 and its attenuated vaccine virus SA14-2-8 were reverse transcribed, amplified by PCR and sequenced. Comparison of the nucleotide sequence of SA14-2-8 vaccine virus with virulent parent SA14 virus and with two other attenuated vaccine viruses derived from SA14 virus (SA14-14-2/PHK and SA14-14-2/PDK) revealed only seven amino acids in the virulent parent SA14 had been substituted in all three attenuated vaccines. Four were in the envelope (E) protein (E-138, E-176, E-315 and E-439), one in non-structural protein 2B (NS2B-63), one in NS3 (NS3-105), and one in NS4B (NS4B-106). the substitutions at E-315 and E-439 arose due to correction of the SA14/CDC sequence published previously by Nitayaphan et al. (Virology 177, 541-552, 1990). The mutations in NS2B and NS3 are in functional domains of the trypsin-like serine protease. Attenuation of SA14 virus may therefore, in part, be due to alterations in viral protease activity, which could affect replication of the virus.
AiharaS.,
RaoC.,
YuY. X.,
LeeT.,
WatanabeK.,
KamiyaT.,
SumiyoshiH.,
HashimotoH.,
NomotoA.1991; Identification of mutations that occurred on the genome of Japanese encephalitis virus during the attenuation process. Virus Genes 5:95–109
AoJ.,
YuY. X.,
TangY. S.,
CuiB. C.,
JiaD. J.,
LiuL. H.1983; Selection of a better immunogenic and highly attenuated live vaccine virus strain of Japanese encephalitis. II. Safety and immunogenicity of live vaccine SA14-14-2 observed in inoculated children. Chinese Journal of Microbiology and Immunology 3:245–248
BlokJ.,
McWilliamS. M.,
ButlerH. C.,
GibbsA. J.,
WeillerG.,
HerringB. L.,
HemsleyA. C.,
AaskovJ. G.,
YoksanS.,
BhamarapravatiN.1992; Comparison of a dengue 2 virus and its candidate vaccine derivative: sequence relationships with the flaviviruses and other viruses. Virology 187:573–590
BrintonM. A.1986; Replication of flaviviruses. In The Togaviridae and Flaviviridae pp 327–374 Edited by
SchlesingerS.,
SchlesingerM. J.
New York: Plenum Press;
CastleE.,
LeidnerU.,
NowakT.,
WenglerG.1986; Primary structure of the West Nile flavivirus genome regions coding for all nonstructural proteins. Virology 149:10–26
ChambersT. J.,
WeirR. C.,
GrakouiA.,
McCourtD. W.,
BazanJ. F.,
FletterickR. J.,
RiceC. M.1990b; Evidence that the N-terminal domain of nonstructural protein NS3 from yellow fever virus is a serine protease responsible for site-specific cleavages in the viral polyprotein. Proceedings of the National Academy of Sciences, USA 87:8898–8902
ChambersT. J.,
NestorowiczA.,
AmbergS. M.,
RiceC. M.1993; Mutagenesis of the yellow fever virus NS2B protein: effects on proteolytic processing, NS2B-NS3 complex formation, and viral replication. Journal of Virology 67:6797–6807
CoiaG.,
ParkerM. D.,
SpeightG.,
ByrneM. E.,
WestawayE. G.1988; Nucleotide and complete amino acid sequences of Kunjin virus: definitive gene order and characteristics of the virus-specific proteins. Journal of General Virology 69:1–21
DalgarnoL.,
TrentD. W.,
StraussJ. H.,
RiceC. W.1986; Partial nucleotide sequence of the Murray Valley encephalitis virus genome – comparison of the encoded polypeptides with yellow fever virus structural and non-structural proteins. Journal of Molecular Biology 187:309–323
EckelsK. H.,
YuY. X.,
DuboisD. R.,
MarchetteN. J.,
TrentD. W.,
JohnsonA. J.1988; Japanese encephalitis virus live attenuated vaccine, Chinese strain SA14-14-2: adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use. Vaccine 6:513–518
FalgoutB.,
MillerR. H.,
LaiC. J.1993; Deletion analysis of dengue virus type 4 nonstructural protein NS2B: identification of a domain required for NS2B–NS3 protease activity. Journal of Virology 67:2034–2042
GunakasemP.,
ChantrasriC.,
SimasathianP.,
ChaiyanunS.,
JatanasenS.,
PariyanonthA.1981; Surveillance of Japanese encephalitis cases in Thailand. Southeast Asian Journal of Tropical Medicine and Public Health 12:333–337
HahnC. S.,
DalrympleJ. M.,
StraussJ. H.,
RiceC. M.1987; Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it. Proceedings of the National Academy of Sciences, USA 84:2019–2023
HashimotoH.,
NomotoA.,
WatanabeK.,
MoriT.,
TakezawaT.,
AizawaC.,
TakegamiT.,
HiramatsuK.1988; Molecular cloning and complete sequence of the genome of Japanese encephalitis virus Beijing-1 strain. Virus Genes 1:305–317
Iacono-ConnorsL.,
SchmaljohnC. S.1992; Cloning and sequences of the genes encoding the nonstructural proteins of langat virus and comparative analysis with other flaviviruses. Virology 188:875–880
LiH. M.1986; Studies on attenuated live JE virus vaccine. In Virus Vaccines in Asian Countries pp 159–165 Edited by
FukaiK.
Tokyo: University of Tokyo Press;
MandlC. W.,
HolzmannH.,
KunzC.,
HeinzF. X.1989; Complete genomic sequence of tick-borne encephalitis virus (western subtype) and comparative analysis of nonstructural proteins with other flavivirus. Virology 173:291–301
NiH.,
BurnsN. J.,
ChangG.-J. J.,
ZhangM.-J.,
WillsM. R.,
TrentD. W.,
SandersP. G.,
BarrettA. D. T.1994; Comparison of nucleotide and deduced amino acid sequence of the 5′ non-coding region and structural protein genes of the wild-type Japanese encephalitis virus strain SA14 and its attenuated vaccine derivatives. Journal of General Virology 75:1505–1510
NitayaphanS.,
GrantJ. G.,
ChangG. J.,
TrentD. W.1990; Nucleotide sequence of virulent SAM strain of Japanese encephalitis virus and its attenuated vaccine derivative, SA14-14-2. Virology 177:541–552
PletnevA. G.,
YamshchikovV. F.,
BlinovV. M.1990; Nucleotide sequence of the genome and complete amino acid sequence of the polyprotein of tick-borne encephalitis virus. Virology 174:250–263
YuY. X.,
AoJ.,
ChuY. G.,
FontT.,
HuangN. J.,
LiuL. H.1973; Study on the variation of Japanese B encephalitis virus. V. The biological characteristics of an attenuated live-vaccine virus strain. Acta Microbiologica Sinica 13:16–24
YuY. X.,
WuP. F.,
AoJ.,
LiuL. H.,
LiH. M.1981; Selection of a better immunogenic and highly attenuated live vaccine virus strain of Japanese encephalitis. I. Some biological characteristics of SAM-14-2 mutant. Chinese Journal of Microbiology and Immunology 1:77–84
YuY. X.,
ZhangG. M.,
GuoY. P.,
AoJ.,
LiH. M.1988; Safety of a live attenuated Japanese encephalitis virus vaccine (SA14-14-2) for children. American Journal of Tropical Medicine and Hygiene 39:214–217